Literature DB >> 25576617

Improvement of LysM-mediated surface display of designed ankyrin repeat proteins (DARPins) in recombinant and nonrecombinant strains of Lactococcus lactis and Lactobacillus Species.

Petra Zadravec1, Borut Štrukelj1, Aleš Berlec2.   

Abstract

Safety and probiotic properties make lactic acid bacteria (LAB) attractive hosts for surface display of heterologous proteins. Protein display on nonrecombinant microorganisms is preferred for therapeutic and food applications due to regulatory requirements. We displayed two designed ankyrin repeat proteins (DARPins), each possessing affinity for the Fc region of human IgG, on the surface of Lactococcus lactis by fusing them to the Usp45 secretion signal and to the peptidoglycan-binding C terminus of AcmA, containing lysine motif (LysM) repeats. Growth medium containing a secreted fusion protein was used to test its heterologous binding to 10 strains of species of the genus Lactobacillus, using flow cytometry, whole-cell enzyme-linked immunosorbent assay (ELISA), and fluorescence microscopy. The fusion proteins bound to the surfaces of all lactobacilli; however, binding to the majority of bacteria was only 2- to 5-fold stronger than that of the control. Lactobacillus salivarius ATCC 11741 demonstrated exceptionally strong binding (32- to 55-fold higher than that of the control) and may therefore be an attractive host for nonrecombinant surface display. Genomic comparison of the species indicated the exopolysaccharides of Lb. salivarius as a possible reason for the difference. Additionally, a 15-fold concentration-dependent increase in nonrecombinant surface display on L. lactis was demonstrated by growing bacteria with sublethal concentrations of the antibiotics chloramphenicol and erythromycin. Nonrecombinant surface display on LAB, based on LysM repeats, was optimized by selecting Lactobacillus salivarius ATCC 11741 as the optimal host and by introducing antibiotics as additives for increasing surface display on L. lactis. Additionally, effective display of DARPins on the surfaces of nonrecombinant LAB has opened up several new therapeutic possibilities.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25576617      PMCID: PMC4345362          DOI: 10.1128/AEM.03694-14

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  41 in total

1.  Novel surface display system for proteins on non-genetically modified gram-positive bacteria.

Authors:  Tjibbe Bosma; Rolf Kanninga; Jolanda Neef; Sandrine A L Audouy; Maarten L van Roosmalen; Anton Steen; Girbe Buist; Jan Kok; Oscar P Kuipers; George Robillard; Kees Leenhouts
Journal:  Appl Environ Microbiol       Date:  2006-01       Impact factor: 4.792

Review 2.  The world of subinhibitory antibiotic concentrations.

Authors:  Julian Davies; George B Spiegelman; Grace Yim
Journal:  Curr Opin Microbiol       Date:  2006-08-30       Impact factor: 7.934

3.  Properties and kinetic analysis of UDP-glucose dehydrogenase from group A streptococci. Irreversible inhibition by UDP-chloroacetol.

Authors:  R E Campbell; R F Sala; I van de Rijn; M E Tanner
Journal:  J Biol Chem       Date:  1997-02-07       Impact factor: 5.157

4.  Cell wall attachment of a widely distributed peptidoglycan binding domain is hindered by cell wall constituents.

Authors:  Anton Steen; Girbe Buist; Kees J Leenhouts; Mohamed El Khattabi; Froukje Grijpstra; Aldert L Zomer; Gerard Venema; Oscar P Kuipers; Jan Kok
Journal:  J Biol Chem       Date:  2003-04-08       Impact factor: 5.157

5.  Characterization of a novel LysM domain from Lactobacillus fermentum bacteriophage endolysin and its use as an anchor to display heterologous proteins on the surfaces of lactic acid bacteria.

Authors:  Shumin Hu; Jian Kong; Wentao Kong; Tingting Guo; Mingjie Ji
Journal:  Appl Environ Microbiol       Date:  2010-02-19       Impact factor: 4.792

6.  System using tandem repeats of the cA peptidoglycan-binding domain from Lactococcus lactis for display of both N- and C-terminal fusions on cell surfaces of lactic acid bacteria.

Authors:  Kenji Okano; Qiao Zhang; Sakurako Kimura; Junya Narita; Tsutomu Tanaka; Hideki Fukuda; Akihiko Kondo
Journal:  Appl Environ Microbiol       Date:  2007-12-21       Impact factor: 4.792

7.  Engineering the cell surface display of cohesins for assembly of cellulosome-inspired enzyme complexes on Lactococcus lactis.

Authors:  Andrew S Wieczorek; Vincent J J Martin
Journal:  Microb Cell Fact       Date:  2010-09-14       Impact factor: 5.328

8.  Expression of a hepatitis A virus antigen in Lactococcus lactis and Escherichia coli and evaluation of its immunogenicity.

Authors:  Aleš Berlec; Tadej Malovrh; Petra Zadravec; Andrej Steyer; Matjaž Ravnikar; Jerica Sabotič; Mateja Poljšak-Prijatelj; Borut Štrukelj
Journal:  Appl Microbiol Biotechnol       Date:  2013-01-31       Impact factor: 4.813

9.  The Response of Enterococcus faecalis V583 to Chloramphenicol Treatment.

Authors:  Agot Aakra; Heidi Vebø; Ulf Indahl; Lars Snipen; Oystein Gjerstad; Merete Lunde; Ingolf F Nes
Journal:  Int J Microbiol       Date:  2010-06-15

10.  Heterologous protein display on the cell surface of lactic acid bacteria mediated by the s-layer protein.

Authors:  Shumin Hu; Jian Kong; Zhilan Sun; Lanlan Han; Wentao Kong; Pu Yang
Journal:  Microb Cell Fact       Date:  2011-10-28       Impact factor: 5.328

View more
  10 in total

1.  Heterologous surface display on lactic acid bacteria: non-GMO alternative?

Authors:  Petra Zadravec; Borut Štrukelj; Aleš Berlec
Journal:  Bioengineered       Date:  2015-04-16       Impact factor: 3.269

2.  Targeting IL-6 by engineered Lactococcus lactis via surface-displayed affibody.

Authors:  Abida Zahirović; Aleš Berlec
Journal:  Microb Cell Fact       Date:  2022-07-16       Impact factor: 6.352

Review 3.  Role of Lactobacillus in cervical cancer.

Authors:  Xi Yang; Miao Da; Wenyuan Zhang; Quan Qi; Chun Zhang; Shuwen Han
Journal:  Cancer Manag Res       Date:  2018-05-16       Impact factor: 3.989

4.  Evasin-displaying lactic acid bacteria bind different chemokines and neutralize CXCL8 production in Caco-2 cells.

Authors:  Katja Škrlec; Anja Pucer Janež; Boris Rogelj; Borut Štrukelj; Aleš Berlec
Journal:  Microb Biotechnol       Date:  2017-07-24       Impact factor: 5.813

Review 5.  Does Lactobacillus Exert a Protective Effect on the Development of Cervical and Endometrial Cancer in Women?

Authors:  Karolina Frąszczak; Bartłomiej Barczyński; Adrianna Kondracka
Journal:  Cancers (Basel)       Date:  2022-10-07       Impact factor: 6.575

Review 6.  The interplay between the vaginal microbiome and innate immunity in the focus of predictive, preventive, and personalized medical approach to combat HPV-induced cervical cancer.

Authors:  Erik Kudela; Alena Liskova; Marek Samec; Lenka Koklesova; Veronika Holubekova; Tomas Rokos; Erik Kozubik; Terezia Pribulova; Kevin Zhai; Dietrich Busselberg; Peter Kubatka; Kamil Biringer
Journal:  EPMA J       Date:  2021-05-18       Impact factor: 8.836

7.  Development of Recombinant Lactococcus lactis Displaying Albumin-Binding Domain Variants against Shiga Toxin 1 B Subunit.

Authors:  Petra Zadravec; Lucie Marečková; Hana Petroková; Vesna Hodnik; Milica Perišić Nanut; Gregor Anderluh; Borut Štrukelj; Petr Malý; Aleš Berlec
Journal:  PLoS One       Date:  2016-09-08       Impact factor: 3.240

8.  Single plasmid systems for inducible dual protein expression and for CRISPR-Cas9/CRISPRi gene regulation in lactic acid bacterium Lactococcus lactis.

Authors:  Aleš Berlec; Katja Škrlec; Janja Kocjan; Maria Olenic; Borut Štrukelj
Journal:  Sci Rep       Date:  2018-01-17       Impact factor: 4.379

Review 9.  Microbial Delivery Vehicles for Allergens and Allergen-Derived Peptides in Immunotherapy of Allergic Diseases.

Authors:  Abida Zahirović; Mojca Lunder
Journal:  Front Microbiol       Date:  2018-07-02       Impact factor: 5.640

10.  Effects of Electrospinning on the Viability of Ten Species of Lactic Acid Bacteria in Poly(Ethylene Oxide) Nanofibers.

Authors:  Špela Zupančič; Katja Škrlec; Petra Kocbek; Julijana Kristl; Aleš Berlec
Journal:  Pharmaceutics       Date:  2019-09-18       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.